BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20525880)

  • 1. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association.
    Rogers KR; Kikawa KD; Mouradian M; Hernandez K; McKinnon KM; Ahwah SM; Pardini RS
    Carcinogenesis; 2010 Sep; 31(9):1523-30. PubMed ID: 20525880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin suppresses lipid raft-mediated signaling and ligand-independent EGF receptor activation.
    Liu YT; Song L; Templeton DM
    J Cell Physiol; 2007 Apr; 211(1):205-12. PubMed ID: 17226785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.
    Liu ZB; Hou YF; Zhu J; Hu DL; Jin W; Ou ZL; Di GH; Wu J; Shen ZZ; Shao ZM
    Oncogene; 2010 May; 29(20):2996-3009. PubMed ID: 20228837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
    Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
    Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
    Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
    Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
    Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
    Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
    Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
    Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells.
    Altenburg JD; Siddiqui RA
    Mol Cancer Res; 2009 Jul; 7(7):1013-20. PubMed ID: 19567784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway.
    German OL; Insua MF; Gentili C; Rotstein NP; Politi LE
    J Neurochem; 2006 Sep; 98(5):1507-20. PubMed ID: 16923163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced oxidative stress and cell death in the A549 lung adenocarcinoma cell line by ionizing radiation is enhanced by supplementation with docosahexaenoic acid.
    Kikawa KD; Herrick JS; Tateo RE; Mouradian M; Tay JS; Pardini RS
    Nutr Cancer; 2010; 62(8):1017-24. PubMed ID: 21058189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition.
    Osada S; Saji S; Osada K
    Cancer; 2001 Mar; 91(6):1156-65. PubMed ID: 11267961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1.
    Schønberg SA; Lundemo AG; Fladvad T; Holmgren K; Bremseth H; Nilsen A; Gederaas O; Tvedt KE; Egeberg KW; Krokan HE
    FEBS J; 2006 Jun; 273(12):2749-65. PubMed ID: 16817902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor tyrosine kinase inhibitor does not improve paclitaxel effect in an orthotopic mouse model of lung cancer.
    Onn A; Isobe T; Wu W; Itasaka S; Shintani T; Shibuya K; Kenji Y; O'reilly MS; Fidler IJ; Herbst RS
    Clin Cancer Res; 2004 Dec; 10(24):8613-9. PubMed ID: 15623645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells.
    Chen ZY; Istfan NW
    Prostaglandins Leukot Essent Fatty Acids; 2000 Nov; 63(5):301-8. PubMed ID: 11090257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
    Lin YJ; Zhen YS
    Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
    Wang CY; Wang YT; Tzeng DW; Yang JL
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway.
    Gu D; Li H; Wang Z; Chen Q; Jiang J; Zhu H
    Laryngoscope; 2007 Oct; 117(10):1782-9. PubMed ID: 17906498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.